feed,title,long_url,short_url
Benzinga,"China Lenalidomide Markets, 2016-2020 & 2021-2025: Sales Value was CNY297.4 Million in 2020 and the CAGR of Lenalidomide from 2016 to 2020 is 98.7%",https://benzinga.com/pressreleases/21/05/g21052803/china-lenalidomide-markets-2016-2020-2021-2025-sales-value-was-cny297-4-million-in-2020-and-the-ca,
